- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: A new era of hormonal therapies is born - Abstract
September 1, 2012
Inflammation and prostate carcinogenesis - Abstract
September 1, 2012
The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer - Abstract
September 1, 2012
Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy - Abstract
September 1, 2012
FDA approves Xtandi (enzalutamide)
September 1, 2012
A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training - Abstract
August 31, 2012
Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer - Abstract
August 31, 2012
Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis - Abstract
August 31, 2012
Effect of body mass index on intrafraction prostate displacement monitored by real-time electromagnetic tracking - Abstract
August 31, 2012
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer - Abstract
August 31, 2012
Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option? - Abstract
August 31, 2012
The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy - Abstract
August 30, 2012